Literature DB >> 19749192

Advanced interpretation of the Neuropsychological Assessment Battery with older adults: base rate analyses, discrepancy scores, and interpreting change.

Brian L Brooks1, Grant L Iverson, Travis White.   

Abstract

The purpose of this study is to provide sophisticated psychometric information for advanced interpretation of the Neuropsychological Assessment Battery (NAB) with older adults. This information includes the base rates of low scores, intellectual-cognitive discrepancy scores, and a method for determining change. The NAB contains 24 co-normed neurocognitive tests across five domains (i.e., Attention, Language, Memory, Spatial, and Executive Functions); provides 36 primary T-scores, five domain indexes, and a total index score; and was co-normed with a measure of intellectual abilities (Reynolds Intellectual Assessment Scales; Reynolds Intellectual Screening Test [RIST]). Participants for this study were 742 older adults from the NAB standardization sample (mean age = 68.1, SD = 6.9). From the standardization sample, 42 older adults (mean age = 67.3 years, SD = 8.3) were administered the NAB two times (mean retest interval = 6.7 months, SD = 0.7). The base rates of low index scores and low primary scores are presented for the entire sample, as well as stratified by the level of intellectual abilities. RIST-NAB discrepancy scores are presented for the entire sample and for the different levels of intellectual abilities. Finally, information needed to interpret change in test performance on serial assessments is provided.

Entities:  

Mesh:

Year:  2009        PMID: 19749192     DOI: 10.1093/arclin/acp061

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  8 in total

1.  To Change is Human: "Abnormal" Reliable Change Memory Scores are Common in Healthy Adults and Older Adults.

Authors:  Brian L Brooks; James A Holdnack; Grant L Iverson
Journal:  Arch Clin Neuropsychol       Date:  2016-12-24       Impact factor: 2.813

2.  Using multivariate base rates of low scores to understand early cognitive declines on the uniform data set 3.0 Neuropsychological Battery.

Authors:  Andrew M Kiselica; Troy A Webber; Jared F Benge
Journal:  Neuropsychology       Date:  2020-04-27       Impact factor: 3.295

3.  Reliable Change on Memory Tests is Common in Healthy Children and Adolescents.

Authors:  Brian L Brooks; James A Holdnack; Grant L Iverson
Journal:  Arch Clin Neuropsychol       Date:  2017-12-01       Impact factor: 2.813

4.  Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB).

Authors:  Panagiota Mistridis; Simone C Egli; Grant L Iverson; Manfred Berres; Klaus Willmes; Kathleen A Welsh-Bohmer; Andreas U Monsch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-03       Impact factor: 5.270

Review 5.  Judgment in Mild Cognitive Impairment and Alzheimer's disease.

Authors:  Patrícia Helena Figueirêdo Vale Capucho; Sonia Maria Dozzi Brucki
Journal:  Dement Neuropsychol       Date:  2011 Oct-Dec

6.  A Multivariate Interpretation of the Spanish-Language NIH Toolbox Cognition Battery: The Normal Frequency of Low Scores.

Authors:  Justin E Karr; Monica Rivera Mindt; Grant L Iverson
Journal:  Arch Clin Neuropsychol       Date:  2022-02-23       Impact factor: 3.448

7.  Results of scoping review do not support mild traumatic brain injury being associated with a high incidence of chronic cognitive impairment: Commentary on McInnes et al. 2017.

Authors:  Grant L Iverson; Justin E Karr; Andrew J Gardner; Noah D Silverberg; Douglas P Terry
Journal:  PLoS One       Date:  2019-09-16       Impact factor: 3.240

8.  Examining Test-Retest Reliability and Reliable Change for Cognition Endpoints for the CENTER-TBI Neuropsychological Test Battery.

Authors:  Jonas Stenberg; Justin E Karr; Rune H Karlsen; Toril Skandsen; Noah D Silverberg; Grant L Iverson
Journal:  Front Neurol       Date:  2020-10-20       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.